Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Nicotinamide Riboside on Myocardial and Skeletal Muscle Injury and Function in Patients With Metastatic Breast Cancer Receiving Anthracyclines

NCT05732051 is registered in ClinicalTrials.gov with University Hospital, Akershus as lead sponsor.

NCT NCT05732051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05732051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Nicotinamide Riboside on Myocardial and Skeletal Muscle Injury and Function in Patients With Metastatic Breast Cancer Receiving Anthracyclines
Lead sponsor
University Hospital, Akershus
Phase
Phase 2
Overall status
Recruiting
Start date
March 16, 2023
Completion date
September 30, 2035
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cancer therapy-related cardiac dysfunction, cardiotoxicity, heart failure, metastatic breast cancer